investment adviser

Lululemon Athletica (LULU) is scheduled to release its financial results on March 29 after the market close. And while half of the 36 analysts who Lululemon rate it a Buy or Outperform, that still means another half, well, don’t.

Kevork Djansezian/Getty Images

Count Macquarie’s Laurent Vasilescu and team among the latter. In a note today, they offered 10 reasons to be cautious about Lululemon, which they rate Underperform. Here are my excerpts:

Same-store Sales: “We are concerned that store comps are in the low single digits, especially since the store fleet is very young,” Vasilescu warns. Margin Disclosure: “The level of disclosure around the gross margin continues to decrease,” Vasilescu claims. Margin Sapping Businesses: “Mens and ivivva are both growth drivers yet they are
margin dilutive,” Vasilescu explains. Too many stores in the U.S.: “Prior management outlined many times the TAM of 300-350 stores in North America,”Vasilescu writes. “Lulu is reaching saturation.” U.S. Store Profitability: It’s much lower than in Canada, claims Vasilescu. Marketing: Not enough of it, especially compared to Nike (NKE), Adidas (ADDYY), and Under Armour (UAA), Vasilescu says. Not a tech company: On its third-quarter conference call, Lululemon said it was a quasi-tech company. It’s not, says Vasilescu. Competition: Denim. Beyonce. Amazon.com (AMZN). Ouch. High costs: “When comps turn negative we think this will pressure earnings, as we estimate high fixed SG&A costs,” write Vasilescu. Inventories: “Days in inventory remain elevated at 112 vs historical 3Q rate of 90,” warns Vasilescu.

Shares of Lululemon Athletica have gained 0.6% to $64.06 at 2:32 p.m. today, while Nike has fallen 0.9% to $55.86, Adidas has dipped 0.1% to $96.27, Under Armour has risen 0.9% to $19.83, and Amazon.com has ticked up 0.1% to $846.38.

investment adviser: Popeyes Louisiana Kitchen, Inc.(PLKI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Popeyes Louisiana Kitchen Inc (NASDAQ: PLKI) is estimated to post its quarterly earnings at $0.64 per share on revenue of $85.31 million.

    SpartanNash Co (NASDAQ: SPTN) is expected to post its quarterly earnings at $0.49 per share on revenue of $2.28 billion.

  • [By Ashley Moore]

    Popeyes Louisiana Kitchen Inc. (Nasdaq: PLKI) stock is up 19% today (Tuesday) after Burger King’s parent company, Restaurant Brands International Inc. (NYSE: QSR), announced it will buy the fast-food chicken company.

  • [By Daniel Miller]

    While chicken and burgers might not sound like a match made in heaven for dinner, it could be tasty for investors inRestaurant Brands International (NYSE:QSR). The parent company of Burger King agreed to purchase Popeyes Louisiana Kitchen Inc. (NASDAQ:PLKI).

investment adviser: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    So here’s a disruptive move. Consider buying auto parts retailer Advance Auto Parts (AAP) , the weakest of the big three in the sector, which has 5,000-plus locations in the U.S. The other two players are O’Reilly Automotive, Inc. (ORLY) , the fastest-growing of the three, and AutoZone, Inc. (AZO) .

  • [By Spencer Israel]

     

    Riot Blockchain Inc (NASDAQ: RIOT) – The Jan. 2015 high of $15.72 is the only resistance it has.
    General Electric Company (NYSE: GE) -The low of the move is a double bottom at $17.46 and  $17.50. That’s support.
    Overstock.com Inc (NASDAQ: OSTK) – The February 2005 high was $58.24, which is the only relevant resistance up here. On weakness, keep an eye on the all-time closing high of $56.65 made on Monday.
    Advance Auto Parts, Inc. (NYSE: AAP) – Is trying to fill the gap from earnings between $82.82 and $94.75.
    Tesla Motors Inc (NASDAQ: TSLA) – It needs to clear Friday’s close of $315.05 and Monday’s high of $315.50 to find support.
    Urban Outfitters, Inc. (NASDAQ: URBN) – There was a double close at $27.90 from Friday and $28.27 from Monday, so that’s resistance.
    DSW Inc. (NYSE: DSW) -The premarket low was $18.40. There are also four daily lows at the $18.40 area from early November, and the low of the move is $17.89.
    Signet Jewelers Ltd. (NYSE: SIG) – the premarket low was $61.50, which was the low of the move. There’s daily lows at the $61 area from mid-August, and another pair of lows at $60. Below that, there’s a gap area down to $52.95.
    Lowe’s Companies, Inc. (NYSE: LOW)- The Friday low was $79.17, and a pair of lows from Wednesday and Thursday at $78.27 and $78.23.
    Campbell Soup Company (NYSE: CPB) – The buy zone is between $45-$46. The low of the move was $44.99, flanked by the $45.14 low the following day.
    Dollar Tree, Inc. (NASDAQ: DLTR) – $99.93 and a big psychological number at $100.
    Burlington Stores Inc (NYSE: BURL) – The Monday low was $104.55. The all-time high and all-time closing high are $106.55 and $106.89, respectively. 
    Exxon Mobil Corporation (NYSE: XOM) – Big triple bottom at $80.

    Watch the full show below!

  • [By ]

    3. Advance Auto Parts (NYSE: AAP)
    A leader in the consumer auto parts space, Advance boasts over 5,200 stores, 100 Worldpac branches, and serves more than 1,300 independently owned CARQUEST branded shops.

  • [By Ben Levisohn]

    Advance Auto Parts (AAP) surged to the top of the S&P 500 today after releasing better-than-expected third-quarter earnings.

    Getty Images

    Shares of Advance Auto Parts gained 15% to $164.33, while the S&P 500 rose 0.8% to 2,180.39.

    Credit Suisse analyst Seth Sigman and team explain why shares of Advance Auto Parts are soaring:

    Advance Auto Parts’ Q3 and strategic update was one of the better scenarios for this stock with better than expected comps, positive commentary on Q4, a roughly in line 2017 outlook, and a new sense of direction on how this new management team will narrow the margin gap with peers. Management guided to a 500 bps long-term margin improvement, which wasnt a surprise to investors, and other specifics were still limited. However, timed with Q3/4′s improvement, this should help instill some early confidence in this team. We are adjusting our 2016 and 2017 EPS modestly, to $7.30 (from $7.23) and to $7.65 (from $7.60) respectively.

    Advance Auto Parts market capitalization rose to $12.1 billion today from $10.7 billion yesterday.

investment adviser: Alphabet Inc.(GOOGL)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Alphabet Inc.’s (NASDAQ: GOOGL) Google was one of the first companies to field early experiments in self-driving cars. By late last year, Google’s vehicles had covered over 2 million miles on public roads. Google has spun out its driverless car operation into a company called Waymo. Its management commented:

  • [By Elizabeth Balboa]

    The marketing and sales software platform is also facing competition from the likes of Alphabet Inc (NASDAQ: GOOGL) and Facebook Inc (NASDAQ: FB).

    “At best, HubSpot is worth SaaS [software as a service] comps,” Left wrote. “We give it the benefit of the doubt and give it take-out valuations… Hubspot is more in line with a content marketing company whose takeout valuations are 2x revenue.”

  • [By Daniel Sparks]

    Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) has put its first-quarter earnings release date on the calendar. The internet search giant will report results for its most recently ended quarter on Thursday, April 27. After missing estimates for earnings per share in its most recent quarter, investors will be watching the company’s profitability closely.

  • [By WWW.THESTREET.COM]

    Are you sensing a little resistance? Cramer and the AAP team look at Apple (AAPL) , Facebook (FB) , Alphabet (GOOGL) , and Schlumberger (SLB) in their weekly roundup. Be ready for the week ahead and find out what they’re telling their investment club members with a free trial subscription to Action Alerts PLUS.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Amazon.com, Inc. (NASDAQ: AMZN): Free Stock Analysis Report
     
    Netflix, Inc. (NASDAQ: NFLX): Free Stock Analysis Report
     
    Facebook, Inc. (NASDAQ: FB): Free Stock Analysis Report
     
    Alphabet Inc. (NASDAQ: GOOGL): Free Stock Analysis Report
     
    Apple Inc. (NASDAQ: AAPL): Free Stock Analysis Report
     
    SPDR-TECH SELS (ETF:XLK): ETF Research Reports
     
    NASDAQ-100 SHRS (NASDAQ: QQQ): ETF Research Reports
     
    SPDR-SP 500 TR (ETF:SPY): ETF Research Reports
     
    PWRSH-DYN SEMI (ETF:PSI): ETF Research Reports
     
    ISHARS-NA TEC-S (ETF:IGV): ETF Research Reports
     
    FIRST N-100 TEC (NASDAQ: QTEC): ETF Research Reports
     
    FT-TECH ALPHA (ETF:FXL): ETF Research Reports
     
    FT-NDQ SEMICON (FTXL): ETF Research Reports
     
    NVIDIA Corporation (NASDAQ: NVDA): Free Stock Analysis Report
     
    Macy's Inc (NYSE: M): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research
     
    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

investment adviser: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

    Read more of Cramer’s comments about the stocks in the Lightning Round.

  • [By WWW.MONEYSHOW.COM]

    Prudential Financial (PRU) is also a major provider of asset management and retirement services. It focuses is on fixed income, a major liability during the past eight years of ultra-low interest rates.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) has long had the Rock of Gibraltar as its corporate symbol, representing its solid financial position. With more cash and equivalents than debt on its balance sheet, and a total cash hoard of over $49 billion, Prudential still looks set up to handle some downright awful insurable losses. That’s its “Rock of Gibraltar” strength showing through.

investment adviser: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Matthew Briar]

    Earlier this month, some light was shed on the so-called marijuana ‘zombie’ outbreak in Brooklyn (and a handful of other places) earlier this year. As it turns out, it wasn’t a zombie outbreak at all… not that anyone really suspected the undead were lurking about. The culprit was drugs, or more specifically, chemicals and compounds that serve as drugs that weren’t meant to be utilized in that manner. In the search for a stronger, more intense high, marijuana fans got far more than they bargained for, and not in good way.

    The matter inadvertently puts an up-and-coming company called Lexaria Bioscience Corp (OTCMKTS:LXRP) in the spotlight. See, Lexaria Bioscience could have sidestepped the zombie-like response of what’s now clearly been deemed a chemical-laced plant nobody would ever actually choose to smoke if they knew better. How so? Because LXRP could have provided the more intense ‘high’ being sought using its infusion science and real marijuana… not the synthetic marijuana that’s been causing unexpected results like hallucinations, extreme agitation, a rapid heartbeat and extremely high blood pressure. paranoia, anxiety, panic attacks and psychotic episodes. Those aren’t the usual responses to weed. They’re common responses to other, harsher narcotics, and are often wished avoided by recreational marijuana users.

    Say what you want about the moral hazards or dangers of legalized marijuana, but nobody can deny that it’s happening… in the United States, and abroad. In November, marijuana was on the ballot for one reason or another in nine states, and the pro-marijuana movement got the green light in eight of them. Weed is now legal, either for medicinal or recreational use, in more than half the states that make up the U.S.A.

    More relevant to the matter at hand, in step with the ongoing legalization of marijuana, users and sellers have — as they always do– pushed the limits of legality and science to come up with a better expe

  • [By James E. Brumley]

    Don’t be surprised if Lexaria Bioscience Corp (OTCMKTS:LXRP) shares seem a little peppier and even more bullish than usual for the next three months, give or take… and that’s saying something considering LXRP is 158% since early October, and up 47% since mid-December. Why’s that? The organization has hired a publicity firm to help tell its story to an even bigger audience, and that attention could attract a whole new batch of buyers for the stock.

    Granted, the Lexaria Bioscience story is a compelling one to begin with.

    If 2016 (and 2017 so far) were to be pegged with any major investment “themes,” cannabis would have to be it. Marijuana/hemp — cannabinoids, ultimately — was on the ballot for one reason or another in nine states this past November, and those pro-cannabis measures passed in eight of those votes. As such, cannabis is now legal for at least one reason in 26 states of the United States, and the movement is still gathering momentum.

    And well it should. The recreational aspect of marijuana and cannabinoids aside, hemp (a form of cannabis plant that isn’t the kind of marijuana that provides a “high”) delivers a multitude of health benefits. Specifically, users of hemp oil find the plant-based oil improves immunity, improves cardiovascular health, moderates blood sugar, treats skin conditions, treats arthritis, inhibits osteoporosis, fights some mental disorders, and in some cases has been found to be an anti-cancer agent. Lexaria Bioscience is simply enhancing these benefits of hemp oil by enhancing the amount of hemp oil a human body can absorb when ingested.

    Simply put, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. The key to the science is the fact that Lexaria Bioscience is able to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is it

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Jim Robertson]

    Small cap Lexaria Bioscience Corp (OTCQB: LXRP)is a food sciences company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies.This technology enables higher bioavailability rates for CBD, THC, NSAIDs, Nicotine and other molecules than is possible without lipophilic enhancement technology allowing for lower overall dosing requirements and/or higher effectiveness in active molecule delivery.The Companyhopes to reduce other common, but less healthy ingestion methods such as smoking as it embraces the benefits of public health.

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.

  • [By James E. Brumley]

    Are hemp and marijuana one and the same? It depends who you ask. The federal government accurately recognizes that hemp and marijuana are variants of the same species, Cannabis sativa. Yet, poodles and German shepherds are also from the same species, and the two couldn’t be any more different types of dogs. The same goes for marijuana and hemp. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), which is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.

    The good news is, governments – federal and state – are finally starting to wise up to the distinct differences between marijuana and hemp, and that bodes well for a young startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

    Lexaria Bioscience Corp. is “a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.”

    In other words, it solves a problem within the budding (no pun intended) world of cannabis and medical — or even recreational — marijuana. It increases the amount of absorption of a substance ingested.

    The science has applications in everything from vitamins to supplements to painkillers, but LXRP is starting with the hemp oil for good reason.

    Hemp seeds (which are technically a nut and are als

Leave a Reply

Your email address will not be published. Required fields are marked *